Should spirometry be performed on a patient with an office blood pressure of 200/100 mmHg who has a confirmed diagnosis of white‑coat hypertension by ambulatory blood pressure monitoring?

Yes, proceed with spirometry—white coat hypertension does not contraindicate pulmonary function testing.

Even with confirmed white coat hypertension by ABPM, an office BP of 200/100 mmHg is safe for spirometry, as the patient's true ambulatory BP is normal and poses no cardiovascular risk during the procedure.

Clinical Reasoning

Understanding the Clinical Context

The key distinction here is between office BP readings (which are artificially elevated due to the white coat effect) and true cardiovascular risk (which is determined by ambulatory BP). Since ABPM has confirmed white coat hypertension, this patient's actual BP outside the medical setting is normal, meaning:

• No increased cardiovascular risk during spirometry: White coat hypertension carries cardiovascular risk similar to normotension, not sustained hypertension 1, 2
• The 200/100 mmHg reading is an artifact of the medical environment, not a reflection of the patient's baseline cardiovascular status
• Target organ damage is minimal: Studies show patients with white coat hypertension have significantly lower left ventricular mass index (102 g/m²) compared to those with sustained hypertension (125 g/m²) 3

Guideline Framework

The 2025 AHA/ACC guidelines clearly state that office BP ≥160/100 mmHg typically warrants prompt treatment 1. However, this recommendation applies to unconfirmed hypertension or sustained hypertension—not to patients with proven white coat hypertension by ABPM. The guidelines emphasize using out-of-office monitoring to exclude white coat hypertension precisely to avoid inappropriate treatment decisions 1.

Practical Approach to Spirometry

Proceed with spirometry while implementing these strategies:

• Minimize white coat effect during testing:

  • Allow adequate rest period (5-10 minutes) before spirometry
  • Use automated BP measurement if checking BP before the procedure
  • Consider having the patient perform home BP monitoring on the day of spirometry to document their true baseline

• No need to delay or cancel the procedure: The confirmed diagnosis of white coat hypertension means the patient's cardiovascular system is not at risk from their true BP load

• Document the ABPM findings clearly in the medical record so other providers understand this is not uncontrolled hypertension

Common Pitfalls to Avoid

1. Don't treat the office BP number in isolation: The entire purpose of obtaining ABPM was to identify exactly this scenario—where office readings are misleading 4, 5

2. Don't require BP normalization before spirometry: This would be treating a measurement artifact rather than actual disease. White coat hypertension patients don't require antihypertensive medication unless they have additional cardiovascular risk factors or target organ damage 1, 6

3. Don't confuse white coat hypertension with hypertensive emergency: A BP of 200/100 mmHg in the office setting, when ABPM shows normal readings, does not constitute a hypertensive emergency and requires no acute intervention

Ongoing Management Considerations

While spirometry can proceed safely, the 2025 AHA/ACC guidelines recommend 1:

• Annual out-of-office BP monitoring to detect progression to sustained hypertension (occurs in a higher proportion compared to those with sustained normotension)
• Lifestyle modifications as appropriate
• No pharmacologic treatment unless cardiovascular risk factors or target organ damage develop 2, 6

The 2024 ESC guidelines similarly support this approach, emphasizing that out-of-office BP measurements provide the reference standard for diagnosis and should guide clinical decisions 4.